1 |
Xue S, Ge W, Wang K, Mao T, Zhang X, Xu H, Wang Y, Yao J, Li S, Yue M, Ma J, Wang Y, Shentu D, Cui J, Wang L. Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Front Cell Dev Biol 2022;10:942225. [DOI: 10.3389/fcell.2022.942225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Liu S, Li H, Zhu Y, Ma X, Shao Z, Yang Z, Cai C, Wu Z, Li M, Gong W, Wu X. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer. Cancer Lett 2022;547:215862. [PMID: 35953000 DOI: 10.1016/j.canlet.2022.215862] [Reference Citation Analysis]
|
3 |
Zhao F, Chang J, Zhao P, Wang W, Sun X, Ma X, Yin M, Wang Y, Yang Y. Oncogenetic Function and Prognostic Value of DNA Topoisomerase II Alpha in Human Malignances: A Pan-Cancer Analysis. Front Genet 2022;13:856692. [DOI: 10.3389/fgene.2022.856692] [Reference Citation Analysis]
|
4 |
Zhang X, Li TY, Xiao HM, Ehrlich KC, Shen H, Deng HW, Ehrlich M. Epigenomic and Transcriptomic Prioritization of Candidate Obesity-Risk Regulatory GWAS SNPs. Int J Mol Sci 2022;23. [PMID: 35163195 DOI: 10.3390/ijms23031271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
5 |
Zhang X, Li T, Xiao H, Ehrlich KC, Shen H, Deng H, Ehrlich M. Epigenomic and transcriptomic prioritization of candidate obesity-risk regulatory GWAS SNPs.. [DOI: 10.1101/2021.10.29.466522] [Reference Citation Analysis]
|
6 |
Xia H, Huang Z, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Li Z, Yu L, Huang P, Kang P, Su Z, Xu Y, Yam JWP, Cui Y. LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors. Biomed Pharmacother 2021;141:111889. [PMID: 34323697 DOI: 10.1016/j.biopha.2021.111889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Jiang X, Cheng Y, He Y, Cong S, Sun L, Wu D, Wu H, Zhang G. LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer. Cancer Manag Res 2021;13:3817-26. [PMID: 34007214 DOI: 10.2147/CMAR.S295097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|